{
    "Allele Frequency": "0.047", 
    "Build 37 Chromosome": "chr2", 
    "Build 37 Position": "202074098", 
    "Build 37 Variant Allele": "A", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Cancer"
    ], 
    "Evidence": "Likely", 
    "Gene Symbol": "CASP10", 
    "Impact": "Protective", 
    "Inheritance": "Dominant", 
    "PMID Count": 2, 
    "PMID List": [
        "10412980", 
        "16251207"
    ], 
    "Scores": {
        "Case/Control": "4", 
        "Computational": "1", 
        "Familial": "0", 
        "Functional": null, 
        "Penetrance": "2", 
        "Severity": "3", 
        "Treatability": "3"
    }, 
    "Summary": "Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).", 
    "URL": "http://evidence.pgp-hms.org/CASP10-V410I", 
    "Variant Name": "CASP10-V410I", 
    "Variant Page": "http://evidence.pgp-hms.org/CASP10-V410I", 
    "dbSNP IDs": [
        "rs13010627"
    ]
}